| ²é¿´: 1461 | »Ø¸´: 4 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
Çó¸ßÊÖ°ïÎÒ·ÒëÕâÒ»¶Î£¬ÓкܶàרҵÊõÓÉúÃü¿ÆÑ§Õâ¿éµÄ³æ×ÓÓ¦¸ÃºÜÊìϤ
|
|||
|
Competitive ELISA for quantification of trastuzumab. Tissues from BT474 tumor mice that received trastuzumab injections were homogenized in 1 ml of 0.1 M Glycine pH2 with 1% Tween-20 and protease inhibitors followed by a centrifugation (4˚C, 10 min, 14,000 rpm). Six hundred microliters of supernatant was collected, and added with 150 ¦Ìl of 1 M Tris pH8 and 22.5 ¦Ìl of 5 M NaCl to neutralize the pH. Microtiter wells coated with 5 mg/ml rabbit anti-human IgG were incubated with the tissue extracts and 1 ¦Ìg/ml of biotinylated human IgG. After 2 hours of incubation at room temperature, the wells were washed with PBS containing 0.01% Tween 20, added with streptavidin-conjugated horseradish peroxidase, and incubated for 30 minutes at room temperature. The amount of biotinylated human IgG captured on the microtiter wells was quantified with 2,2-azino-bis(3-etylbenzthiazoline-6-sulfonic acid) as a substrate and the absorbance at 405 nm was measured. To obtain standard curves, the tissue extracts were substituted with various concentrations of trastuzumab (ranging from 0.01 to 10 ¦Ìg/ml) in the ELISA. |
» ²ÂÄãϲ»¶
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ17È˻ظ´
¹ú×ÔÈ»ÃæÉϸ´ÅÌ~»¶ÓÌÖÂÛ
ÒѾÓÐ9È˻ظ´
¿´°åÉÏÕâô¶àÖеģ¬ÓеãÏñ50ÈËȺÀï49¸öÈ˶¼ÊÇÆ×ÓµÄÄÇÖָоõ¡¡
ÒѾÓÐ6È˻ظ´
µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡
ÒѾÓÐ6È˻ظ´
Çà»ùÈçºÎÆÆ¾Ö
ÒѾÓÐ4È˻ظ´
»ù½ð²»ÖУ¬¹²Ãã
ÒѾÓÐ8È˻ظ´
»ù½ðδÖУ¬ÕâÖÖ´ð¸´ÊÇÄ£°åÂð£¿
ÒѾÓÐ5È˻ظ´
Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ
ÒѾÓÐ5È˻ظ´
Ôõô¿´Çà»ùÖÐÁËûÓа¡
ÒѾÓÐ5È˻ظ´
ÃÎÏë
ÒѾÓÐ3È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
·¢µã½ð±ÒÍæ
+5/715
ÃæÉϵÃÖÐ
+1/493
2026Ä깤³Ì¹ÜÀíÓëÖǻ۳ÇÊйú¼Ê»áÒé (EMSC 2026)
+1/253
Öйú»ù£¬É¢½ð±Ò£¡£¡£¡£¡£¡£¡
+5/204
¶«»ª´óѧ²ÄÁÏ¿ÆÑ§Ó빤³ÌѧԺ¶¡ÆæÀÏʦÕÐÊÕ2026¼¶Ë¶Ê¿Ñо¿Éú
+1/100
±±¾©»¯¹¤´óѧºÎ¾²½ÌÊÚÍÅ¶Ó³ÏÆ¸ÇàÄêÓ¢²ÅºÍ²©Ê¿ºó
+1/100
ÏÖÔÚÉúÎïÒ½Ò©Ïà¹ØÓÐʲô¼æÖ°¿ÉÒÔ×öÂð£¿
+1/36
ÐÂÉó²éÖ¸Ä϶ÂËÀÁË"Ò»°¸Ë«Éê"µÄÀÏ·£¬ÊµÓÃÐÂÐͺͷ¢Ã÷Ö»ÄܶþѡһÁË£¿
+1/23
¹ú¼Òµ°°×ÖÊ¿ÆÑ§ÖÐÐÄ£¨±±¾©£©£¬ÕÐÊÕ·ÖÎö»¯Ñ§¡¢Ò©Ñ§ºÍµ°°×ÖÊ×é´úл×éѧ²©Ê¿Ñо¿Éú
+1/22
¹ú¼Òµ°°×ÖÊ¿ÆÑ§ÖÐÐÄ£¨±±¾©£©£¬ÕÐÊÕ·ÖÎö»¯Ñ§¡¢Ò©Ñ§ºÍµ°°×ÖÊ×é´úл×éѧ²©Ê¿Ñо¿Éú
+1/20
Õã½´óѧҽѧԺ»ÆºÆ½Ü½ÌÊÚÍŶÓÕÐÆ¸4-5Ãû²©Ê¿ºó
+1/9
ϸ°ûÖÎÁÆÈ«Á÷³Ì¹Ø¼ü¼ì²â¼¼ÊõÓëÑо¿²ßÂÔ
+1/5
ÏîÄ¿ÖúÀíÕÐÆ¸ÆôÊÂ
+1/5
ÖпÆÔº´óÁ¬»¯Ñ§ÎïÀíÑо¿Ëù ÕÐÆ¸ ´ß»¯¼ÁÑз¢·½Ïò ¿ÆÑÐÖúÀí 2Ãû
+1/4
ÄϾ©´óѧ ÖÇÄÜÇý¶¯Óë¸ÐÖª²ÄÁÏʵÑéÊÒ ³ÏÕÐÉêÇ뿼ºË²©Ê¿Éú/¿ÆÑÐÖúÀí/²©Ê¿ºó
+1/4
EI»áÒéÕ÷¸å£¡µÚ¶þ½ìÏȽø¸´ºÏ²ÄÁÏ¡¢¾ÛºÏÎïºÍÄÉÃ×¼¼Êõ¹ú¼ÊѧÊõ»áÒé(ACMPN 2027)
+1/3
ÄÏ·½Ò½¿Æ´óѧÉîÛÚÒ½Ôº³ÂìÇ/ÓàÌνÌÊÚ¿ÎÌâ×éÁªºÏÅàÑø²©Ê¿ºóÕÐÆ¸
+1/2
Á¿×ÓÎïÀíÍŶÓÕÐÊÕ²©Ê¿ÉúÓ벩ʿºó
+1/1
ÖØ´óÍ»ÆÆ£¡Ã¸·¨ºÏ³ÉÆÆ½âÉúÎï·¨DNAºÏ³ÉÔÁÏ¡°¿¨²±×Ó¡±ÄÑÌâ
+1/1
¡¾2027Äê9ÔÂÈëѧ¡¿Äþ²¨¶«·½Àí¹¤´óѧÁªÅ಩ʿÉú(Öпƴó/ÉϽ»´ó)ÕÐÉú£¨ÎïÀí/²ÄÁÏ·½Ïò£©
+1/1
5Â¥2010-12-07 19:16:24
gary8812
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 58
- Ó¦Öú: 11 (СѧÉú)
- ¹ó±ö: 0.005
- ½ð±Ò: 9278
- Ìû×Ó: 1781
- ÔÚÏß: 1158.4Сʱ
- ³æºÅ: 607349
2Â¥2010-12-05 19:27:42
ringzhu
ľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 24
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ¹ó±ö: 1.318
- ½ð±Ò: 1370.6
- Ìû×Ó: 4511
- ÔÚÏß: 703.5Сʱ
- ³æºÅ: 825134
3Â¥2010-12-07 16:03:58
4Â¥2010-12-07 19:15:08









»Ø¸´´ËÂ¥